 |
|
Genetic mutation linked to West Nile virus infection
January 09, 2006A genetic mutation that protects against HIV increases the risk of developing clinical West Nile Virus infection, according to a new study appearing online on January 9th in The Journal of Experimental Medicine.
The mutation in question is a small deletion in a gene that encodes a protein called CCR5, which was identified in 1996 as a co-receptor used by HIV to infect cells. Individuals with two copies of this mutation (CCR5delta32) are highly resistant to HIV infection, even when repeatedly exposed to the virus.
This resistance was the theoretical basis for the development of therapeutic CCR5 inhibitors, several of which are now in clinical trials, for the treatment of patients with HIV. CCR5 seemed like an ideal drug target, as people missing the receptor were healthy and no diseases or infections had been shown to be more frequent or severe in individuals carrying the CCR5delta32 mutation.
But new evidence suggests that the lack of CCR5 is not completely innocuous. Philip Murphy and his colleagues at the National Institute of Allergy and Infectious Diseases (Bethesda, MD) recently showed that infection with WNV - a mosquito-borne virus that caused a1999 outbreak of fatal encephalitis in the US - was uniformly fatal in mice that lack CCR5.
This finding prompted Murphy and his colleagues to look for the CCR5delta32 mutation in patients in the US who were diagnosed with WNV infections. They now report that individuals with two copies of CCR5delta32 were more frequent among WNV patients than in the general population, suggesting that the lack of CCR5 puts people at risk for developing clinical WNV infections. In mice, the lack of CCR5 prevents protective immune cells from gaining access to the brain where they can fight off the infection. It remains to be seen whether the same mechanism is at play in humans.
This study might raise a red flag for the use of CCR5 inhibitors in HIV-infected patients - at least in areas endemic for WNV - as such inhibitors might increase the recipients' vulnerability to severe WNV infection.
Journal of Experimental Medicine
But new evidence suggests that the lack of CCR5 is not completely innocuous. Philip Murphy and his colleagues at the National Institute of Allergy and Infectious Diseases (Bethesda, MD) recently showed that infection with WNV - a mosquito-borne virus that caused a1999 outbreak of fatal encephalitis in the US - was uniformly fatal in mice that lack CCR5.
This finding prompted Murphy and his colleagues to look for the CCR5delta32 mutation in patients in the US who were diagnosed with WNV infections. They now report that individuals with two copies of CCR5delta32 were more frequent among WNV patients than in the general population, suggesting that the lack of CCR5 puts people at risk for developing clinical WNV infections. In mice, the lack of CCR5 prevents protective immune cells from gaining access to the brain where they can fight off the infection. It remains to be seen whether the same mechanism is at play in humans.
This study might raise a red flag for the use of CCR5 inhibitors in HIV-infected patients - at least in areas endemic for WNV - as such inhibitors might increase the recipients' vulnerability to severe WNV infection.
Journal of Experimental Medicine
West Nile Virus Current Events and West Nile Virus News RSSOn the Trail of a Vaccine for Lyme Disease: Yale Researchers Target Tick Saliva
A protein found in the saliva of ticks helps protect mice from developing Lyme disease, Yale researchers have discovered. The findings, published in the November 19 issue of Cell Host & Microbe, may spur development of a new vaccine against infection from Lyme disease, which is spread through tick bites.
UC Davis researchers identify dominant chemical that attracts mosquitoes to humans
Scientists at the University of California, Davis, have identified the dominant odor naturally produced in humans and birds that attracts the blood-feeding Culex mosquitoes, which transmit West Nile virus and other life-threatening diseases.
What are coral reef services worth? $130,000 to $1.2 million per hectare, per year: experts
Experts concluding the global DIVERSITAS biodiversity conference today in Cape Town described preliminary research revealing jaw-dropping dollar values of the "ecosystem services" of biomes like forests and coral reefs - including food, pollution treatment and climate regulation.
Immune cells predict outcome of West Nile virus infection
Infection with West Nile virus (WNV) causes no symptoms in most people. However, it can cause fever, meningitis, and/or encephalitis. What determines the outcome of infection with WNV in different people has not been determined.
Surgical masks and N95 respirators provide similar protection against influenza
A McMaster University study has found that surgical masks appear to be as good as N95 respirators in protecting health-care workers against influenza.
La Jolla Institute announces 2.0 launch of major database to aid vaccine development worldwide
Key improvements in a major infectious disease database that will aid vaccine development worldwide were unveiled today with the 2.0 launch of the National Institutes of Health-sponsored Immune Epitope Database and Analysis Resource (IEDB).
OHSU scientists partner with others to form center aimed at combating infectious diseases
Oregon Health & Science University and the University of Washington, along with a number of partner institutions across the Northwest, have received federal funding to form a regional research center aimed at combating emerging or re-emerging infectious diseases that pose a serious threat to human health.
Field stations foster serendipitous discoveries in environmental, biological sciences
North America's biological field stations have long been home to a rich legacy of research results, scientists say, making them important places for serendipitous discoveries in the biological and environmental sciences.
New wheat disease could spread faster than expected
Both plant and human diseases that can travel with the wind have the potential to spread far more rapidly than has been understood, according to a new study, in findings that pose serious concerns not only for some human diseases but also a new fungus that threatens global wheat production.
New test may help to ensure that dengue vaccines do no harm
As vaccines against a virus that infects 100 million people annually reach late-stage clinical trials this year, researchers have developed a test to better predict whether a given vaccine candidate should protect patients from the infection, or in some cases, make it more dangerous, according to an article just published in the journal Clinical and Vaccine Immunology.
More West Nile Virus Current Events and West Nile Virus News Articles
 |
West Nile Virus (Diseases and Disorders) by Melissa Abramovitz (Author) West Nile virus had never been seen in the Western Hemisphere before 1999. Now, it's everywhere in the United States. Find out more about this new health threat and what's being done about it. (20051001) |
 |
Recombitek West Nile 10 Dose (1 mL) by Recombitek Recombitek West Nile Virus Vaccine is recommended for the vaccination of healthy horses as an aid in the prevention of viremia due to West Nile Virus infection. This is Live Canarypox Vector vaccine. Reconstitute the lyophilized vaccine with accompanying liquid diluent and aseptically inject a 1ml dose by intramuscular route. For primary vaccination, revaccinate with a second 1 ml dose of this product 4 to 6 weeks later. Annual revaccination with a single dose is recommended. This contains 10 Doses: 10 x 1 Dose, Lyophilized 10 x 1 mL, Sterile Diluent Doseage: Reconstitute the lyophilized vaccine with accompanying liquid diluent and aseptically inject a 1 ml dose by intramuscular route. For primary vaccinate with a second 1 ml dose of this product 4 to 6 weeks later. Annual revaccination... |
![West Nile Virus [Explicit]](http://ecx.images-amazon.com/images/I/511096CMYZL._SL160_.jpg) |
West Nile Virus [Explicit] Brotha Lynch Hung (Primary Contributor) |
 |
ThermaCELL Mosquito Repellent Refill Set 1 set by ThermaCELL Mosquito repellent refills. |
 |
Off! Insect Repellent II, Aerosol, Fresh Scent - 15% DEET (no longer unscented), 6 oz by OFF! Provides hours of effective protection from mosquitoes, gnats and biting flies (deer flies, sand flies, stable flies and black flies). Also repels ticks, chiggers and fleas from treated skin and clothing. OFF! Insect Repellent II is not greasy, won't stain and resists perspiration. Sprays upside down too. Contains No CFCs or other ozone depleting substances. |
|
West Nile Virus by Catcher | |
 |
FaceDoctorX Anti-Mosquito Soap, 100 g (3.35 oz) by Face Doctor The new way to stop mosquitoes from biting! Non-Toxic, No side effects, Contains 100% herbal extracts! The unique formula found in this soap was developed by Dr. Archibald of the Australian National Biological Laboratory. It contains 100% herbal extraction. Once you shower with this soap, it will repel mosquitoes from touching your skin. It will also relieve insect bites and itching if you did not use the soap offhand. Active Ingredients Function: Eucalyptus oil: Repel mosquitoes, relieve tired muscles. Citronella oil: mosquito repellent. Menthol: Insect and mosquito repellent, refreshes and revitalizes skin. Lavendula: Represses bacteria, diminishes inflammation. Calendula: Diminishes inflammation, relieves itching. Made in China. |
|
Protecting Yourself and Your Community From West Nile Virus x VHS tape | |
 |
West Nile Virus (Deadly Diseases and Epidemics) by Jeffrey N. Sfakianos (Author), I. Edward Alcamo (Editor), David Heymann (Editor) Often a serious illnes, West Nile Virus seems to arise as a seasonal epidemic in North America, beginning in the summer and continuing into the fall. |
|
West Nile Virus Plush in Plastic Petri Dish [Toy] by Giant Microbes |
| © 2009 BrightSurf.com |